Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Recombinant fragment corresponding to a region within amino acids 82 and 320 of Human RCBTB1|
|Purification||Antigen affinity chromatography|
|Storage buffer||0.1M tris glycine, pH 7, with 20% glycerol|
|Storage Conditions||-20° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|Western Blot (WB)||1:500-1:3000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
PA5-30673 targets RCBTB1 in WB applications and shows reactivity with Human samples.
The PA5-30673 immunogen is recombinant fragment corresponding to a region within amino acids 82 and 320 of Human RCBTB1.
This gene encodes a protein with an N-terminal RCC1 domain and a C-terminal BTB (broad complex, tramtrack and bric-a-brac) domain. In rat, over-expression of this gene in vascular smooth muscle cells induced cellular hypertrophy. In rat, the C-terminus of RCBTB1 interacts with the angiotensin II receptor-1A. In humans, this gene maps to a region of chromosome 13q that is frequently deleted in B-cell chronic lymphocytic leukemia and other lymphoid malignancies.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
chronic lymphocytic leukemia deletion region gene 7 protein; CLL deletion region gene 7 protein; CLLD7; CLLL7; GDP/GTP exchange factor (GEF)-like protein; GLP; regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 1; regulator of chromosome condensation and BTB domain-containing protein 1; RP11-185C18.1
CLLD7; CLLL7; E4.5; GLP; RCBTB1